Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab vs Corticosteroids in High Risk COVID-19
NCT04345445Phase 3Unknown
- Sponsor
- Universiti Malaya
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 3 trial of tocilizumab in coronavirus disease 2019 (COVID-19), sponsored by Universiti Malaya. Status: unknown.
02
Drugs
tocilizumab
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04345445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04345445.